stage ii breast cancer

Showing 51 - 75 of 104

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer Trial in Chicago (eribulin mesylate,

Unknown status
  • Estrogen Receptor-negative Breast Cancer
  • +10 more
  • eribulin mesylate
  • +2 more
  • Chicago, Illinois
    Northwestern University
Jun 6, 2019

Sleep Disorder, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in United States (Brief Behavioral Therapy, Telephone-Based

Completed
  • Sleep Disorder
  • +6 more
  • Brief Behavioral Therapy
  • +2 more
  • Stanford, California
  • +5 more
Jun 3, 2019

Ductal Breast Carcinoma In Situ, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in Los Angeles (Contrast-enhanced Magnetic

Completed
  • Ductal Breast Carcinoma In Situ
  • +3 more
  • Contrast-enhanced Magnetic Resonance Imaging
  • +4 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
May 14, 2019

Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Cleveland (trastuzumab, Pertuzumab,

Completed
  • Stage II Breast Cancer
  • +3 more
  • trastuzumab
  • +7 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Feb 14, 2019

Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Winston-Salem (other, behavioral, procedure)

Completed
  • Stage IA Breast Cancer
  • +6 more
  • educational intervention
  • +4 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jan 23, 2019

Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in Boston (Herceptin, Navelbine, Doxorubicin)

Completed
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 11, 2019

HER2-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Omaha (drug, biological, other)

Terminated
  • HER2-negative Breast Cancer
  • +4 more
  • doxorubicin hydrochloride
  • +6 more
  • Omaha, Nebraska
    UNMC Eppley Cancer Center at the University of Nebraska Medical
Dec 10, 2018

HER2-positive Breast Cancer, Male Breast Cancer, Stage II Breast Cancer Trial in Rochester (HER-2/neu peptide vaccine,

Completed
  • HER2-positive Breast Cancer
  • +5 more
  • HER-2/neu peptide vaccine
  • laboratory biomarker analysis
  • Rochester, Minnesota
    Mayo Clinic
Oct 4, 2018

Ductal Carcinoma in Situ, Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Completed
  • Ductal Carcinoma in Situ
  • +7 more
  • Baltimore, Maryland
    Johns Hopkins University
Aug 14, 2018

Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer Trial in Columbus (Best Practice, Exercise

Unknown status
  • Stage II Breast Cancer
  • +6 more
  • Best Practice
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 7, 2018

Cardiovascular Complications, Recurrent Breast Cancer, Stage I Breast Cancer Trial in Winston-Salem (drug, other, procedure)

Terminated
  • Cardiovascular Complications
  • +7 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 30, 2018

Estrogen Receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Male Breast Cancer Trial

Terminated
  • Estrogen Receptor-positive Breast Cancer
  • +6 more
  • Tucson, Arizona
    Arizona Cancer Center
Jul 23, 2018

Breast Cancer, Inflammatory Breast Cancer, Stage I Breast Cancer Trial in Cleveland (MUC-1 peptide vaccine, poly ICLC, MUC1

Completed
  • Breast Cancer
  • +7 more
  • MUC-1 peptide vaccine
  • +5 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Jul 19, 2018

Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Winston-Salem (other, behavioral, procedure)

Completed
  • Stage I Breast Cancer
  • +5 more
  • questionnaire administration
  • +5 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 2, 2018

Cognitive/Functional Effects, Recurrent Breast Cancer, Stage IA Breast Cancer Trial in Winston-Salem (ultrasound imaging,

Completed
  • Cognitive/Functional Effects
  • +7 more
  • ultrasound imaging
  • +4 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 2, 2018

Anxiety Disorder, Depression, Ductal Breast Carcinoma in Situ Trial in Winston-Salem (yoga therapy, internet-based intervention,

Terminated
  • Anxiety Disorder
  • +9 more
  • yoga therapy
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jun 29, 2018

Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer Trial in Seattle

Completed
  • Estrogen Receptor-negative Breast Cancer
  • +8 more
  • doxorubicin hydrochloride
  • +13 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 12, 2018

Stage I Breast Cancer, Stage I Cervical Cancer, Stage I Ovarian Cancer Trial in Philadelphia, Reading (Informational

Completed
  • Stage I Breast Cancer
  • +38 more
  • Informational Intervention
  • Philadelphia, Pennsylvania
  • +1 more
Feb 20, 2018

Anxiety Disorder, Depression, Ductal Breast Carcinoma in Situ Trial in Seattle (educational intervention, counseling

Completed
  • Anxiety Disorder
  • +10 more
  • educational intervention
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 6, 2018

Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer Trial in Duarte, Pasadena (acupuncture therapy, questionnaire

Terminated
  • Breast Cancer
  • +5 more
  • acupuncture therapy
  • +2 more
  • Duarte, California
  • +1 more
Nov 2, 2017

Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Tucson (diindolylmethane, )

Completed
  • Stage IA Breast Cancer
  • +3 more
  • diindolylmethane
  • placebo
  • Tucson, Arizona
    Arizona Cancer Center
Oct 31, 2017

HER2-positive Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Houston, Shinjuku-ku, Chuo-ku (drug,

Completed
  • HER2-positive Breast Cancer
  • +2 more
  • lapatinib ditosylate
  • +5 more
  • Houston, Texas
  • +2 more
Aug 9, 2017

Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Stage IA Breast Cancer Trial in Seattle (drug,

Completed
  • Estrogen Receptor-positive Breast Cancer
  • +8 more
  • doxorubicin hydrochloride
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 30, 2017

Male Breast Cancer, Nausea and Vomiting, Stage I Breast Cancer Trial in Seattle (drug, procedure, other)

Completed
  • Male Breast Cancer
  • +4 more
  • palonosetron hydrochloride
  • +8 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 10, 2017